Recognition of drug margin will trigger unfair trade competition

The domestic pharmaceutical industry has recently denounced the government's drug related policy to allow the drug margin up to 50 percent on the medical institutions which will purchase the lowest insurance-covered drugs in the same therapeutic category, in a bid to discourage the use of the high-priced drugs for better financial stability in the national health insurance sector. They have ins...